Clarius Group LLC’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$270K Hold
1,316
0.02% 311
2025
Q3
$207K Sell
1,316
-955
-42% -$148K 0.01% 379
2025
Q2
$382K Sell
2,271
-206
-8% -$30.6K 0.02% 302
2025
Q1
$341K Sell
2,477
-29
-1% -$3.7K 0.02% 315
2024
Q4
$296K Sell
2,506
-220
-8% -$25.7K 0.02% 325
2024
Q3
$301K Sell
2,726
-94
-3% -$9.83K 0.02% 315
2024
Q2
$277K Sell
2,820
-27
-0.9% -$2.75K 0.02% 329
2024
Q1
$319K Sell
2,847
-313
-10% -$33.8K 0.02% 321
2023
Q4
$319K Sell
3,160
-337
-10% -$33.4K 0.03% 332
2023
Q3
$304K Sell
3,497
-1,171
-25% -$106K 0.03% 331
2023
Q2
$441K Buy
4,668
+45
+1% +$3.8K 0.03% 289
2023
Q1
$349K Buy
4,623
+554
+14% +$41.8K 0.03% 341
2022
Q4
$313K Buy
4,069
+35
+0.9% +$2.66K 0.03% 371
2022
Q3
$269K Buy
+4,034
New +$256K 0.03% 375

Other funds holding CAH

Clarius Group LLC's CAH Position: Q4 2025 in Review

Clarius Group LLC held its Cardinal Health (CAH) position steady in Q4 2025 at 1,316 shares worth $270K. The position accounts for 0.02% of the portfolio, ranked #311.

Clarius Group LLC first reported a position in CAH in Q3 2022 and has held it in 14 quarters since. The position peaked at $441K in Q2 2023. 1,406 funds tracked by Wall St. Rank hold CAH as of Q4 2025.

  • Clarius Group LLC held 1,316 shares of Cardinal Health worth $270K as of Q4 2025.
  • Clarius Group LLC left its Cardinal Health share count unchanged in Q4 2025.
  • Cardinal Health made up 0.02% of Clarius Group LLC's portfolio in Q4 2025, its #311 holding.
  • Clarius Group LLC first reported a position in Cardinal Health in Q3 2022 and has held it in 14 quarters since.
  • Clarius Group LLC's Cardinal Health position peaked at $441K in Q2 2023.
  • 1,406 funds tracked by Wall St. Rank held Cardinal Health as of Q4 2025.

Based on Clarius Group LLC's 13F filing for Q4 2025, filed 14 Jan 2026.